Palisade Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62
Closed -$663 516
2025
Q3
$663 Buy
+62
New +$608 ﹤0.01% 543
2024
Q2
Sell
-126
Closed -$2.37K 329
2024
Q1
$2.37K Buy
+126
New +$2.16K ﹤0.01% 375

Other funds holding OGN

Palisade Asset Management's OGN Position: Q4 2025 in Review

Palisade Asset Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 62 shares — an estimated $663 sold.

Palisade Asset Management first reported a position in OGN in Q1 2024 and held it in 2 quarters. The position peaked at $2.37K in Q1 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Palisade Asset Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Palisade Asset Management sold 62 Organon & Co shares in Q4 2025, an estimated $663.
  • Palisade Asset Management first reported a position in Organon & Co in Q1 2024 and held it in 2 quarters.
  • Palisade Asset Management's Organon & Co position peaked at $2.37K in Q1 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.